Dietary fats, cholesterol and iron as risk factors for Parkinson's disease
Open accessAbstract
Background Epidemiologic findings suggest that dietary components may contribute to the etiology of Parkinson's disease (PD). This population-based case-control study evaluated PD risk and dietary intake of fats, cholesterol and iron. Methods Newly diagnosed case (n=420) and age/gender/ethnicity-matched unrelated controls (n=560) were identified between 1992 and 2006 from the Group Health Cooperative health maintenance organization in western Washington State, and the University of Washington Neurology Clinic. In-person interviews elicited data on food frequency habits during most of adult life. Nutritional intakes were calculated and analyzed, with adjustments made for total energy intake (the 'nutrition density' technique). Results Cholesterol intake in the highest quartile compared with the lowest quartile was associated with a decreased risk of PD in men (odds ratio (OR)=0.53, 95%CI: 0.33, 0.86). The highest versus the lowest quartile of dietary iron increased PD risk in men (OR=1.82, 95%CI: 1.11, 2.99). When the lowest quartile of cholesterol and the highest quartile for iron were compared to the highest quartile of cholesterol and the lowest quartile of iron, no association was seen in women, but for men PD risk was increased (OR=2.70, 95%CI: 1.26, 5.76). Saturated fat intake below the median in combination with iron intake above the median also increased the PD risk (OR=1.50, 95%CI: 1.07, 2.11) in both genders combined. Conclusions A low intake of cholesterol, particularly in the presence of high iron, may be associated with an increased risk for PD.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In men, the highest level of iron intake is associated with increased risk of Parkinson's disease.
“In men, the highest level of iron intake was associated with increased risk of PD.”
From Iron, Oxidative Stress and Health (2012) · cites this paper as Powers et al (2009)
A combination of low saturated fat intake with high iron is linked to moderate risk of Parkinson's disease in both sexes, with the association being stronger for men.
“A combination of low saturated fat intake with high iron was linked to moderate risk in both sexes, with the association being stronger for men.”
From Iron, Oxidative Stress and Health (2012) · cites this paper as Powers et al (2009)
Cites
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053 · see citing works
Wang, G.-J., Volkow, N. D., Logan, J., Pappas, N. R., Wong, C. T., Zhu, W., Netusll, N., & Fowler, J. S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03643-6 · Cited by 1,864 · see citing works
(1990) · Choice Reviews Online · doi:10.5860/choice.27-5795 · Cited by 1,049 · see citing works
Cholesterol metabolism in the brain
Dietschy, J. M., & Turley, S. D. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00003 · Cited by 906 · see citing works
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.1.102 · Cited by 647 · cited 2× · see citing works
“Subjects with a score less than 24 on the Standardized MiniMental State Examination (SMMSE) [13], a brief cognitive screen to establish competence for providing accurate responses, were excluded from the study.”
Molloy, D., Alemayehu, E., & Roberts, R. E. (1991) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199100530-00020 · Cited by 488 · see citing works
Lovastatin decreases coenzyme Q levels in humans.
Folkers, K., Langsjoen, P. H., Willis, R. A., Richardson, P. C., Xia, L., Ye, C. Q., & Tamagawa, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.8931 · Cited by 426 · see citing works
An [18F]dopa–PET and clinical study of the rate of progression in Parkinson’s disease
Morrish, P., Sawle, G. V., & Brooks, D. J. (1996) · Brain · doi:10.1093/brain/119.2.585 · Cited by 366 · see citing works
Weight loss in Parkinson's disease
Chen, H., Zhang, S. M., Hernán, M. Á., Willett, W. C., & Ascherio, A. (2003) · Annals of Neurology · doi:10.1002/ana.10577 · Cited by 295 · see citing works
Parkinson’s disease risks associated with dietary iron, manganese, and other nutrient intakes
Powers, K. M., Smith-Weller, T., Franklin, G. M., Longstreth, W. T., Swanson, P. D., & Checkoway, H. (2003) · Neurology · doi:10.1212/01.wnl.0000068021.13945.7f · Cited by 268 · see citing works
Self-citationDietary fatty acids and the risk of Parkinson disease
de Lau, L. M. L., Bornebroek, M., Witteman, J. C. M., Albert Hofman, D., Koudstaal, P. J., & Breteler, M. M. B. (2005) · Neurology · doi:10.1212/01.wnl.0000166038.67153.9f · Cited by 260 · see citing works
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
Simon, K. C., Chen, H., Schwarzschild, M. A., & Ascherio, A. (2007) · Neurology · doi:10.1212/01.wnl.0000271883.45010.8a · Cited by 231 · see citing works
Serum Cholesterol Levels and the Risk of Parkinson's Disease
de Lau, L. M. L., Koudstaal, P. J., Albert Hofman, D., & Breteler, M. M. B. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj283 · Cited by 205 · see citing works
Abbott, R. D., Ross, G. W., White, L. R., Sanderson, W. T., Burchfiel, C. M., Kashon, M. L., Sharp, D. S., Masaki, K., Curb, J. D., & Petrovitch, H. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1306-7 · Cited by 200 · see citing works
Consumption of Dairy Products and Risk of Parkinson's Disease
Chen, H., O’Reilly, É. J., McCullough, M. L., Rodriguez, C., Schwarzschild, M. A., Calle, E. E., Thun, M. J., & Ascherio, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwk089 · Cited by 189 · see citing works
Somayajulu, M., McCarthy, S., Hung, M.-Y., Sikorska, M., Borowy‐Borowski, H., & Pandey, S. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.021 · Cited by 183 · see citing works
Reduced Risk Factors for Vascular Disorders in Parkinson Disease Patients
Scigliano, G., Musicco, M., Soliveri, P., Piccolo, I., Ronchetti, G., & Girotti, F. (2006) · Stroke · doi:10.1161/01.str.0000217384.03237.9c · Cited by 182 · see citing works
Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease
Pappert, E. J., Goetz, C. G., Niederman, F. G., Raman, R., & Leurgans, S. E. (1999) · Movement Disorders · doi:10.1002/1531-8257(199901)14:1 · Cited by 180 · see citing works
Self-citationAdult nutrient intake as a risk factor for Parkinson's disease
Johnson, C. C. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.6.1102 · Cited by 173 · see citing works
Epidemiology versus genetics in parkinson's disease: Progress in resolving an age‐old debate
Langston, J. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440707 · Cited by 165 · see citing works
Therapeutic effects of coenzyme Q 10 (CoQ 10 ) and reduced CoQ 10 in the MPTP model of Parkinsonism
Cléren, C., Yang, L., Lorenzo, B. J., Calingasan, N. Y., Schomer, A. C., Sireci, A. N., Wille, E. J., & Beal, M. F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05097.x · Cited by 158 · see citing works
Diet and Parkinson's disease: A potential role of dairy products in men
Chen, H., Zhang, S. M., Hernán, M. Á., Willett, W. C., & Ascherio, A. (2002) · Annals of Neurology · doi:10.1002/ana.10381 · Cited by 146 · see citing works
Dietary Intakes of Fat and Risk of Parkinson's Disease
Chen, H. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg073 · Cited by 126 · see citing works
Determinants of plasma coenzyme Q<sub>10</sub> in humans
Kaikkonen, J., Nyyssönen, K., Tuomainen, T.-P., Ristonmaa, U., & Salonen, J. T. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01712-8 · Cited by 97 · see citing works
Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer’s disease
Reiss, A. B., Siller, K. A., Rahman, M. M., Chan, E. S. L., Ghiso, J. A., & de Leon, M. J. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.11.009 · Cited by 94 · see citing works
Cholesterol--Making or Breaking the Synapse
Barres, B. A., & Smith, S. J. (2001) · Science · doi:10.1126/science.1066724 · Cited by 87 · see citing works
(1998) · PubMed · Cited by 74 · see citing works
Wolk, A., Bergström, R., Hansson, L., & Nyrén, O. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514630 · Cited by 35 · see citing works
Determinants of long‐term (24‐year) diet recall ability using a 21‐item food frequency questionnaire
Kuzma, J. W., & Lindsted, K. D. (1989) · Nutrition and Cancer · doi:10.1080/01635588909514013 · Cited by 25 · see citing works
Flagged first, then by citations
1 of the 30 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199 · see citing works
Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors
Klingelhoefer, L., & Reichmann, H. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.197 · Cited by 598 · see citing works
Véjux, A., & Lizard, G. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.02.006 · Cited by 291 · see citing works
The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson’s Disease
Galvagnion, C. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171103 · Cited by 265 · see citing works
The Role of Lipids in Parkinson’s Disease
Xicoy, H., Wieringa, B., & Martens, G. J. M. (2019) · Cells · doi:10.3390/cells8010027 · Cited by 255 · see citing works
Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?
Tomé, C. M. L., Tyson, T., Rey, N. L., Grathwohl, S. A., Britschgi, M., & Brundin, P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8267-8 · Cited by 237 · see citing works
Parkinson’s disease from the gut
Liddle, R. A. (2018) · Brain Research · doi:10.1016/j.brainres.2018.01.010 · Cited by 219 · see citing works
Epidemiology of Parkinson's Disease—East Versus West
Abbas, M. M., Xu, Z., & Tan, L. C. S. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12568 · Cited by 194 · see citing works
Brain Iron Metabolism Dysfunction in Parkinson’s Disease
Jiang, H. F., Wang, J., Rogers, J. T., & Xie, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9879-1 · Cited by 183 · see citing works
Peng, B., Yang, Q., B Joshi, R., Liu, Y., Akbar, M., Song, B.-J., Zhou, S., & Wang, X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072316 · Cited by 156 · see citing works
Dietary fat intake, pesticide use, and Parkinson's disease
Kamel, F., Goldman, S. M., Umbach, D. M., Chen, H., Richardson, G., Barber, M. R., Meng, C., Marras, C., Korell, M., Kasten, M., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.09.023 · Cited by 127 · see citing works
Emerging roles for cholesterol in Huntington's disease
Valenza, M., & Cattaneo, E. F. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.06.005 · Cited by 123 · see citing works
High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice
Bousquet, M., St‐Amour, I., Vandal, M., Julien, P., Cicchetti, F., & Calon, F. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.009 · Cited by 110 · see citing works
Omega-3 fatty acids in neurodegenerative diseases: Focus on mitochondria
Eckert, G. P., Lipka, U., & Muller, W. E. (2012) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2012.05.006 · Cited by 109 · see citing works
Widening the Spectrum of Risk Factors, Comorbidities, and Prodromal Features of Parkinson Disease
Schrag, A. E., Bohlken, J., Dammertz, L., Teipel, S. J., Hermann, W., Akmatov, M. K., Bätzing, J., & Holstiege, J. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.3902 · Cited by 96 · see citing works
Zhang, W., Yan, Z., Gao, J., Sun, L., Huang, X., Liu, Z., Yu, S., Cao, C.-J., Zuo, L.-J., Chen, Z., et al. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8586-4 · Cited by 90 · see citing works
Zuo, L.-J., Yu, S., Hu, Y., Wang, F., Piao, Y., Lian, T., Yu, Q.-J., Wang, R., Li, L., Guo, P., et al. (2016) · Scientific Reports · doi:10.1038/s41598-016-0018-z · Cited by 93 · see citing works
Omega-3 polyunsaturated fatty acids in the brain: metabolism and neuroprotection
Zhang, W. (2011) · Frontiers in bioscience · doi:10.2741/3878 · Cited by 92 · see citing works
Prasanthi, J. R. P., Feist, G., Thomasson, S., Thompson, A. J., Schommer, E., & Ghribi, O. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05736.x · Cited by 88 · see citing works
RetractedPrediger, R. D., Aguiar, A. S., MATHEUS, F. C., Walz, R., Antoury, L., Raisman‐Vozari, R., & Doty, R. L. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9281-8 · Cited by 88 · see citing works
Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease–Parkinson's disease overlap?
Marwarha, G., & Ghribi, O. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.013 · Cited by 87 · see citing works
Senescent Microglia: The Key to the Ageing Brain?
Greenwood, E. K., & Brown, D. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094402 · Cited by 84 · see citing works
Marwarha, G., Rhen, T., Schommer, T., & Ghribi, O. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07497.x · Cited by 82 · see citing works
RetractedLi, X., Si, W., Li, Z., Tian, Y., Liu, X., Ye, S., Huang, Z., Ji, Y., Zhao, C., Hao, X., et al. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4894 · Cited by 71 · see citing works
Nicotine from edible Solanaceae and risk of Parkinson disease
Nielsen, S. S., Franklin, G. M., Longstreth, W. T., Swanson, P. D., & Checkoway, H. (2013) · Annals of Neurology · doi:10.1002/ana.23884 · Cited by 71 · see citing works
Self-citationDietary patterns and risk of Parkinson’s disease: a case–control study in Japan
Okubo, H., Miyake, Y., Sasaki, S., Murakami, K., Tanaka, K., Fukushima, W., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03600.x · Cited by 70 · see citing works
Bronstein, J. M., Carvey, P. M., Chen, H., Cory‐Slechta, D. A., Monte, D. A. D., Duda, J. E., English, P. B., Goldman, S. M., Grate, S. J., Hansen, J., et al. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11702 · Cited by 69 · see citing works
Emerging Mechanisms and Targeted Therapy of Ferroptosis in Neurological Diseases and Neuro-oncology
Wang, Y., Tang, B., Zhu, J., Yu, J., Hui, J., Xia, S., & Ji, J. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72251 · Cited by 68 · see citing works
Ikeda, K., Nakamura, Y., Kiyozuka, T., Aoyagi, J., Hirayama, T., Nagata, R., Ito, H., Iwamoto, K., Murata, K., Yoshii, Y., et al. (2011) · Neurodegenerative Diseases · doi:10.1159/000323265 · Cited by 66 · see citing works
Astroglial and microglial contributions to iron metabolism disturbance in Parkinson's disease.
Song, N., Wang, J., Jiang, H., & Xie, J.-X. (2018) · Biochimica et Biophysica Acta - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.008 · Cited by 59 · see citing works
Agrawal, S., Berggren, K. L., Marks, E. S., & Fox, J. H. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux015 · Cited by 61 · see citing works
Yang, W., Chang, Z., Que, R., Weng, G., Deng, B., Wang, T., Huang, Z., Xie, F., Wei, X., Yang, Q., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00053 · Cited by 55 · see citing works
Ferroptosis and Neurodegenerative Diseases: Insights into the Regulatory Roles of SLC7A11
Wang, C., Liu, H., Xu, S., Deng, Y. L., Xu, B., Yang, T., & Liu, W. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01343-7 · Cited by 56 · see citing works
The role of nutrition on Parkinson’s disease: a systematic review
Bianchi, V. E., Rizzi, L., & Somaa, F. A. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2073107 · Cited by 57 · see citing works
Intensity-dependent facial emotion recognition and cognitive functions in Parkinson’s disease
Assogna, F., Pontieri, F. E., Cravello, L., Peppe, A., Pierantozzi, M., Stefani, A., Stanzione, P., Pellicano, C., Caltagirone, C., & Spalletta, G. (2010) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617710000755 · Cited by 54 · see citing works
Primary vision and facial emotion recognition in early Parkinson's disease
Hipp, G., Diederich, N. J., Pieria, V., & Vaillant, M. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.12.047 · Cited by 54 · see citing works
Jakubec, M., Bariås, E., Furse, S., Govasli, M. L., George, V., Turcu, D. C., Iashchishyn, I. A., Morozova‐Roche, L. A., & Halskau, Ø. (2020) · FEBS Journal · doi:10.1111/febs.15551 · Cited by 52 · see citing works
Voigt, R. M., Wang, Z., Brown, J. M., Engen, P. A., Naqib, A., Goetz, C. G., Hall, D. A., Metman, L. V., Shaikh, M., Forsyth, C. B., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105780 · Cited by 51 · see citing works
Relationship between high dietary fat intake and Parkinson’s disease risk: a meta-analysis
Sun, Q., Qu, Y., Chen, X., & Xu, M. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.262599 · Cited by 51 · see citing works
Ferroptosis: underlying mechanisms and involvement in neurodegenerative diseases
Wang, Y., Li, H., He, Q., Zou, R., Cai, J., & Zhang, L. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01902-9 · Cited by 53 · see citing works
Role of Serum Cholesterol in Parkinson's Disease: A Meta-Analysis of Evidence
Gudala, K., Bansal, D., & Muthyala, H. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130196 · Cited by 50 · see citing works
Metal Exposure and Risk of Parkinson Disease: A Systematic Review and Meta-Analysis
Zhao, Y., Ray, A., Portengen, L., Vermeulen, R. C. H., & Peters, S. (2023) · American Journal of Epidemiology · doi:10.1093/aje/kwad082 · Cited by 47 · see citing works
Lipid dysfunction and pathogenesis of multiple system atrophy
Bleasel, J. M., Wong, J. H., Halliday, G. M., & Kim, W. S. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-15 · Cited by 47 · see citing works
Dietary intake of iron, zinc, copper, and risk of Parkinson’s disease: a meta-analysis
Cheng, P., Jia, Y., Huang, W. C., Bai, S., Zhu, X., Qi, Z., Shao, W., & Xie, P. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2349-0 · Cited by 46 · see citing works
Yang, K., Zeng, L., Zeng, J., Deng, Y., Wang, S., Xu, H., He, Q., Yuan, M., Luo, Y., Ge, A., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102063 · Cited by 45 · see citing works
HFE gene variants, iron, and lipids: a novel connection in Alzheimer’s disease
Ali-Rahmani, F., Schengrund, C., & Connor, J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00165 · Cited by 48 · see citing works
Dietary fat intake and risk for Parkinson's disease
Dong, J., Beard, J. D., Umbach, D. M., Park, Y., Huang, X., Blair, A. E., Kamel, F., & Chen, H. (2014) · Movement Disorders · doi:10.1002/mds.26032 · Cited by 42 · see citing works
Wang, C., Wang, D., Zhang, T., Yanagita, T., Xue, C., Chang, Y., & Wang, Y. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.09.027 · Cited by 42 · see citing works
Dietary cholesterol, fats and risk of Parkinson's disease in the Singapore Chinese Health Study
Tan, L., Methawasin, K., Tan, E., Tan, J. H., Au, W., Yuan, J., & Koh, W. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-310065 · Cited by 42 · see citing works
Cardiovascular risk factors and the risk of Parkinson’s disease
Vikdahl, M., Bäckman, L., Johansson, I., Forsgren, L., & Håglin, L. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.259 · Cited by 40 · see citing works
Schommer, J., Marwarha, G., Nagamoto‐Combs, K., & Ghribi, O. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00552 · Cited by 38 · see citing works
Macronutrients intake and risk of P arkinson's disease: A meta‐analysis
Wang, A., Lin, Y., Wu, Y., & Zhang, D. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12321 · Cited by 38 · see citing works
Association between serum lipid levels over time and risk of Parkinson’s disease
Hurh, K., Park, M., Jang, S.-I., Park, E.-C., & Jang, S.-Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-25180-8 · Cited by 35 · see citing works
Sleep Disorders in Parkinson’s Disease: Clinical Features, Iron Metabolism and Related Mechanism
Yu, S., Sun, L. Z., Liu, Z., Huang, X., Zuo, L., Cao, C.-J., Zhang, W., & Wang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082924 · Cited by 34 · see citing works
Zhang, Y., Liu, H., Ning, L., Gu, W., & Liu, X. (2020) · Talanta · doi:10.1016/j.talanta.2020.121853 · Cited by 34 · see citing works
Mahapatra, A., Mandal, N., & Chattopadhyay, K. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c03533 · Cited by 31 · see citing works
Serum cholesterol levels and the risk of multiple system atrophy: A case‐control study
Lee, P. H., Lim, T. S., Shin, H., Yong, S. W., Nam, H. S., & Sohn, Y. H. (2009) · Movement Disorders · doi:10.1002/mds.22459 · Cited by 27 · see citing works
Negative interpretation of social cue in depression: Evidence from reading mind from eyes test
Nejati, V. (2017) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2017.11.001 · Cited by 26 · see citing works
Schommer, J., Marwarha, G., Schommer, T., Flick, T., Lund, J., & Ghribi, O. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0420-5 · Cited by 26 · see citing works
RetractedDrobny, A., Ngo, P. A., Neurath, M. F., Zunke, F., & López-Posadas, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655123 · Cited by 24 · see citing works
Excessive Iron and α-Synuclein Oligomer in Brain are Relevant to Pure Apathy in Parkinson Disease
Wang, F., Yu, S., Zuo, L.-J., Cao, C.-J., Hu, Y., Chen, Z.-J., Piao, Y., Wang, Y., Wang, X., Chen, S., et al. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716632918 · Cited by 23 · see citing works
Shen, X., Yang, H., Zhang, D., & Jiang, H. F. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00939 · Cited by 21 · see citing works
Huang, H., Chen, J., Lu, H., Zhou, M., Chai, Z., & Hu, Y. (2017) · BioMetals · doi:10.1007/s10534-017-0059-1 · Cited by 20 · see citing works
Zhang, Q., CHENG-WU, L., Zhang, T., Ge, Y., Han, X., Sun, S., Ding, J., Lu, M., & Hu, G. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.08.006 · Cited by 20 · see citing works
Liu, L., Shen, Q., Bao, Y., Xu, F., Zhang, D., Huang, H., Tu, L.-D., & Xu, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1278128 · Cited by 19 · see citing works
Serum Cholesterol and Nigrostriatal R2* Values in Parkinson's Disease
Du, G., Lewis, M. M., Shaffer, M. L., Chen, H., Yang, Q. X., Mailman, R. B., & Huang, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035397 · Cited by 19 · see citing works
Zinc protection against aluminium induced altered lipid profile and membrane integrity
Singla, N., & Dhawan, D. K. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.12.047 · Cited by 18 · see citing works
Graphene Quantum Dot Embedded Hydrogel for Dissolved Iron Sensing
Pincher, D. W. M., Bader, C. A., Hayball, J. D., Plush, S. E., & Sweetman, M. J. (2019) · ChemistrySelect · doi:10.1002/slct.201901779 · Cited by 18 · see citing works
Iron, Oxidative Stress and Health
Udipi, S., Ghugre, P., & Gokhale, C. (2012) · Oxidative Stress - Molecular Mechanisms and Biological Effects · doi:10.5772/34975 · Cited by 17 · see citing works
“…leads dopaminergic neuron death in the substantia nigra (Logroscino et al., 2008). www.intechopen.com Oxidative Stress – Molecular Mechanisms and Biological Effects 92 Powers et al (2009) studied dietary intakes of 266 men and 154 women who were newly diagnosed patients with idiopathic PD.”
BackgroundMicronutrients and Risk of Parkinson’s Disease
Sherzai, A. Z., Tagliati, M., Park, K., Pezeshkian, S., & Sherzai, D. (2016) · Gerontology and Geriatric Medicine · doi:10.1177/2333721416644286 · Cited by 15 · see citing works
Cao, B., Guo, X., Chen, K. G., Song, W., Huang, R., Wei, Q., Zhao, B., & Shang, H. (2013) · Neurological Research · doi:10.1179/1743132813y.0000000277 · Cited by 14 · see citing works
Diagnostics and Treatments of Iron-Related CNS Diseases
Xiong, H., Tuo, Q., Guo, Y., & Lei, P. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_10 · Cited by 14 · see citing works
Bioactive lipids and their metabolism: New therapeutic opportunities for Parkinson's disease
Shen, W., Jiang, L., Zhao, J., Wang, H., Hu, M., Chen, L., & Chen, Y. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15566 · Cited by 13 · see citing works
Takeuchi, H., & Kawashima, R. (2022) · Nutrients · doi:10.3390/nu14214671 · Cited by 13 · see citing works
Jakubec, M., Bariås, E., Furse, S., Govasli, M. L., George, V., Turcu, D. C., Iashchishyn, I. A., Morozova‐Roche, L. A., & Halskau, Ø. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/725762 · Cited by 13 · see citing works
Liu, J., Chen, Y., Lu, X., Xu, X., Bulloch, G., Zhu, S., Zhu, Z., Ge, Z., Wang, W., Shang, X., et al. (2023) · Nutrients · doi:10.3390/nu15020260 · Cited by 10 · see citing works
Bellamri, M., Brandt, K., Cammerrer, K., Syeda, T., Turesky, R. J., & Cannon, J. R. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00109 · Cited by 10 · see citing works
The Olfactory System as a Route of Delivery for Agents to the Brain and Circulation
Genter, M. B., Krishan, M., & Prediger, R. D. (2015) · doi:10.1002/9781118971758.ch19 · Cited by 9 · see citing works
Risk factors associated with gallstone disease in women
Paracha, P. I., Asif, Y., Vriesekoop, F., Ullah, S., Abbas, M. N., Paracha, S. I., & Khan, T. (2012) · e-SPEN Journal · doi:10.1016/j.clnme.2012.03.001 · Cited by 7 · see citing works
Liu, Y., Shi, Z., & Liu, J. (2025) · Nutritional Neuroscience · doi:10.1080/1028415x.2024.2436818 · Cited by 6 · see citing works
A new anticoagulant medication in cardiac valve replacement.
Washio, M., Sakashita, I., Nakamura, C., Ohtani, S. I., Asano, K., Matsuzawa, T., & Nishida, Y. (1978) · PubMed · Cited by 6 · see citing works
Mo, Y., Zhong, J., Teng, M., Peng, J., Huang, H., Aschner, M., & Jiang, Y. (2025) · Journal of Applied Toxicology · doi:10.1002/jat.4833 · Cited by 5 · see citing works
A Perfusion MRI Study of Emotional Valence and Arousal in Parkinson’s Disease
Limsoontarakul, S., Campbell, M. C., & BLACK, K. J. (2011) · Parkinson s Disease · doi:10.4061/2011/742907 · Cited by 5 · see citing works
Nutrient signaling pathways regulate amyloid clearance and synaptic loss in Alzheimer’s diseasePreprint
Mondal, M., Bali, J., Tzioras, M., Paolicelli, R. C., Jawaid, A., Malnar, M., Dominko, K., Udayar, V., Halima, S. B., Vadodaria, K. C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.13.381186 · Cited by 3 · see citing works
CNS regulation of plasma cholesterol
Pérez–Tilve, D., Davidson, W. S., Tschöp, M. H., & Hofmann, S. M. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.590819 · Cited by 2 · see citing works
Epidemiology of Parkinson’s Disease—Current Understanding of Causation and Risk Factors
Patil, R. R. (2021) · Series in bioengineering · doi:10.1007/978-981-16-3056-9_3 · Cited by 1 · see citing works
Role of dietary antioxidants and redox status in Parkinson's disease
Amani, R., & Mehrabani, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89834-8.00048-9 · Cited by 1 · see citing works
Jbaily, H. (2023) · Preprints.org · doi:10.20944/preprints202312.2099.v1 · Cited by 1 · see citing works
Serum cholesterol and triglycerides in Parkinson’s disease and essential tremor
Ivanov, B., Kaprelyan, A. G., Dimitrov, I., Грудкова, М., Usheva, N., Nestorova, V., & Deleva, N. S. (2015) · Biomedical Reviews · doi:10.14748/bmr.v26.1543
Do Increased Levels of Oxysterols Underlie Alzheimer’s Disease/Parkinson’s Disease Overlap?
Ghribi, O. (2012) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000e111
ENVIRONMENTAL PERSPECTIVES ENVIRONMENTAL PERSPECTIVES
Bronstein, J. M., Carvey, P. M., Chen, H., Cory‐Slechta, D. A., Monte, D. A. D., Duda, J. E., English, P. B., Goldman, S. M., Grate, S. J., Hansen, J., et al. (2008)
PARKINSON’S DISEASE: A REVIEW ON ETIOPATHOGENESIS AND HERBAL THERAPY
Patel, P., Jivani, N. P., & Malaviya, S. (2013) · Journal of Pharmaceutical and Scientific Innovation · doi:10.7897/2277-4572.02201
EARLY RECOGNITION OF COGNITIVE ABILITY AND NUTRITIONAL MARKERS FOR DEMENTIA IN PARKINSON’S DISEASE
Håglin, L., Bäckman, L., Linder, J., Forsgren, L., & Domellöf, M. (2018) · Journal of Aging Research and Lifestyle · doi:10.14283/jarcp.2018.26
Italian Journal of Prevention, Diagnostic and Therapeutic Medicine
Perciballi, L. (2019) · doi:10.30459/2019-17
α-Synuclein-targeted nanoparticles
Obulesu, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819882-7.00009-x
(2011) · Elsevier eBooks · doi:10.1016/b978-0-7295-3908-1.10031-4
A Parkinson-kór epidemiológiája
Markó-Kucsera, M. (2021) · doi:10.14232/phd.10844
Biological relationship between Parkinson's disease and gallstone disease
Jiang, C., Ma, J., Mu, J., Fu, Y., Zhao, Y., You, Y., Cui, Z., & Guo, C. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70021
Жукова, Н. Г., Sayfitdinkhuzhaev, Z. F., Абдусаломовна, Н. Д., Zhukova, I. A., Okhunboev, J. M., Masenko, A. Y., & Gaponova, O. V. (2025) · Annals of Clinical and Experimental Neurology · doi:10.17816/acen.1275
The Emerging Parkinson's Disease Oxylipin‐Ome
Kelliher, J. C., & Fanning, S. (2026) · Advanced Science · doi:10.1002/advs.202522997
- Authors
- Powers, K. M., Smith-Weller, T., Franklin, G. M., Longstreth, W. T., Swanson, P. D., & Checkoway, H.
- Affiliations
- University of Washington (US)
- Corresponding author
- Checkoway, Harvey
- Venue
- Parkinsonism & Related Disorders
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 15
- Issue
- 1
- Pages
- 47-52
- ISSN
- 1353-8020 (ISSN-L)
- PMC
- PMC2751763
- OpenAlex
- W1974873933
- Cited by
- 100
- References
- 30
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 9 · 2022: 6 · 2021: 7 · 2020: 6 · 2019: 6 · 2018: 7 · 2017: 5 · 2016: 4 · 2015: 5 · 2014: 7 · 2013: 8 · 2012: 6
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Parkinsonism & Related Disorders (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Washington
- National Institutes of Health
- U.S. Public Health Service (R0110750)
- National Institute of Environmental Health Sciences (P42ES004696)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- Parkinson's disease, dietary cholesterol
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cholesterol, Dietary Fats, Humans, Iron, Middle Aged, Parkinson Disease, Retrospective Studies, Risk Factors, Sex Factors, Confidence Intervals, Odds Ratio, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review